Alexion Pharmaceuticals News
Most Popular Alexion Pharmaceuticals Story
R&D success puts Alexion at the top of the M&A list
There's nothing like a successful development record when it comes to attracting attention as a potential M&A target. For Alexion, you can also add new research for Soliris, the world's most Read more...
Latest Headlines
- February 17, 2011
- April 29, 2010
- January 4, 2010
- January 9, 2008
- June 11, 2006
- January 25, 2006
- November 22, 2005
- September 6, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
